VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
VYNE
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
VYNEVYNE Therapeutics Inc.
$39.50$26M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksVYNEQuarterly Balance Sheet

VYNE Therapeutics Inc. (VYNE) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

VYNE Therapeutics Inc. (VYNE) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

VYNE Balance Sheet

Quarterly statement

VYNE Balance Sheet

VYNE Therapeutics Inc. (VYNE) balance sheet — 11-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Total Current Assets30.01K25.79M30.01M35.89M44.34M54.91M64.44M73.53M83.78M90.22M95.96M17.51M22.96M33.02M38.27M44.05M51.92M60.65M63.19M76.13M
Cash & Short-Term Investments29.01K24.93M29.01M32.7M39.65M50.27M61.52M70.19M78.1M86M93.25M15.45M20.63M30.21M30.91M35.51M42.81M50.49M42.25M52.31M
Cash Only24.03K24.63M24.03M19.35M22.05M28.21M19.93M16.27M29.61M19.12M30.62M15.45M20.63M30.21M30.91M35.51M42.81M50.49M42.25M52.31M
Short-Term Investments4.98K297K4.98M13.35M17.6M22.06M41.59M53.91M48.49M66.89M62.63M000000000
Accounts Receivable00000000000250K234K105K5M5.47M5.3M5.54M7.58M10.08M
Days Sales Outstanding-----------195.3114.262.32K80.28K2.97K3.91K3.32K354.577.25K
Inventory0000000000054K67K000007.29M8.07M
Days Inventory Outstanding------------------782.5126.86K
Other Current Assets0861K1M3.19M4.7M4.64M2.92M3.35M5.67M4.22M2.71M1.76M2.02M67K240K67K30K729K1.5M605K
Total Non-Current Assets1.5K84K150K246K375K1.51M2.47M2.66M2.87M1.45M1.72M1.76M2M2.24M2.48M2.86M3.27M3.67M3.86M5.19M
Property, Plant & Equipment9084K90K96K134K169K206K122K151K180K207K0000127K298K310K354K1.51M
Fixed Asset Turnover13.56x0.99x1.40x1.47x0.46x1.08x0.51x0.89x1.20x0.51x0.37x----0.79x0.41x0.54x2.46x0.08x
Goodwill00000000000000000000
Intangible Assets00000000000000000000
Long-Term Investments00000000000000000000
Other Non-Current Assets1.41K060K150K241K1.34M2.26M2.54M2.72M1.27M1.51M1.76M2M2.24M2.48M2.73M2.97M3.35M3.51M3.68M
Total Assets30.16K25.87M30.16M36.13M44.72M56.42M66.91M76.2M86.65M91.68M97.69M19.27M24.96M35.26M40.76M46.91M55.19M64.32M67.05M81.31M
Asset Turnover0.04x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.01x0.00x0.00x0.00x0.00x0.00x0.00x0.03x0.00x
Asset Growth %-99.93%-54.14%-54.92%-52.58%-48.39%-38.45%-31.51%295.48%247.16%159.98%139.67%-58.93%-54.78%-45.17%-39.21%-42.31%-58.81%-56.88%-28.48%-24.49%
Total Current Liabilities2.4K1.24M2.4M4.04M5.84M12.29M14.82M12.66M11.75M6.93M7.54M6.45M6.37M7.52M9.35M6.84M6.83M8.59M18.41M21M
Accounts Payable1.04K261K1.04M1.2M1.41M3.53M2.71M3.99M4.52M2.79M1.66M716K1.16M2.21M2.39M2.52M1.43M3.61M6.51M7.62M
Days Payables Outstanding-9.77K----------------719.8529.08K
Short-Term Debt00000000000000000000
Deferred Revenue (Current)00000000000000000000
Other Current Liabilities41386K413K1.71M819K1.84M2.74M2.38M2.05M3.64M1.65M4.45M4.38M4.39M2.58M2.15M1.86M1.55M2.96M3.49M
Current Ratio12.53x20.86x12.53x8.87x7.60x4.47x4.35x5.81x7.13x13.02x12.73x2.72x3.60x4.39x4.10x6.44x7.60x7.06x3.43x3.63x
Quick Ratio12.53x20.86x12.53x8.87x7.60x4.47x4.35x5.81x7.13x13.02x12.73x2.71x3.59x4.39x4.10x6.44x7.60x7.06x3.04x3.24x
Cash Conversion Cycle------------------417.235.03K
Total Non-Current Liabilities0000000025K1.38M1.41M1.31M1.31M1.31M211K00001.43M
Long-Term Debt00000000000000000000
Capital Lease Obligations0000000025K63K99K00000000775K
Deferred Tax Liabilities00000000000000000000
Other Non-Current Liabilities0000000001.31M1.31M1.31M1.31M1.31M211K0000657K
Total Liabilities2.4K1.24M2.4M4.04M5.84M12.29M14.82M12.66M11.78M8.31M8.95M7.76M7.69M8.83M9.56M6.84M6.83M8.59M18.41M22.43M
Total Debt000025K63K99K123K145K180K214K0000031K117K349K1.05M
Net Debt-24.03K-24.63M-24.03M-19.35M-22.02M-28.15M-19.83M-16.15M-29.46M-18.94M-30.41M-15.45M-20.63M-30.21M-30.91M-35.51M-42.78M-50.38M-41.9M-51.25M
Debt / Equity----0.00x0.00x0.00x0.00x0.00x0.00x0.00x-----0.00x0.00x0.01x0.02x
Debt / EBITDA------------------0.03x-
Net Debt / EBITDA-------------------3.47x-
Interest Coverage--------------------3.11x
Total Equity27.77K24.64M27.77M32.09M38.88M44.13M52.09M63.54M74.87M83.37M88.73M11.51M17.27M26.43M31.2M40.07M48.36M55.73M48.64M58.89M
Equity Growth %-99.93%-44.17%-46.69%-49.5%-48.07%-47.06%-41.3%452.26%333.47%215.43%184.39%-71.29%-64.28%-52.57%-35.85%-31.95%-35.43%-40.01%29.72%18.92%
Book Value per Share0.6528.8032.4637.5345.4751.7161.1574.6087.9097.90142.893.515.288.1110.4512.4515.0318.1116.3620.37
Total Shareholders' Equity27.77K24.64M27.77M32.09M38.88M44.13M52.09M63.54M74.87M83.37M88.73M11.51M17.27M26.43M31.2M40.07M48.36M55.73M48.64M58.89M
Common Stock33K3K3K2K2K1K1K1K1K1K00006K6K6K5K5K
Retained Earnings-757.65K-761.24M-757.65M-752.82M-745.54M-739.78M-731.17M-719.15M-706.99M-697.59M-691.34M-685.15M-678.56M-668.51M-662.74M-652.79M-643.33M-634.86M-639.52M-627.96M
Treasury Stock00000000000000000000
Accumulated OCI002K4K-2K020K34K-58K-70K26K000000000
Minority Interest00000000000000000000